Patient Engagement Solutions & Innovations World Congress 2026 Europe

“Part of Patient Centricity & Collaboration Series”

Transforming Care Through Technology, Empathy, and Collaboration.

  • 00Days
  • 00Hours
  • 00Minutes
  • 00Seconds

Patient Engagement Solutions & Innovations

Transforming Care Through Technology, Empathy, and Collaboration. 

We are delighted to welcome you to our upcoming PATIENT ENGAGEMENT SOLUTIONS &  INNOVATIONS World Congress 2026 Europe, hosted by FACILITATE LIVE. This year’s congress focuses on “Transforming Care Through Technology, Empathy, and Collaboration

In an era defined by accelerated digital transformation, patient engagement has become a strategic imperative for the pharmaceutical and healthcare sectors. Beyond improving clinical outcomes, it is reshaping how organizations create value, differentiate therapies, and build trust in a data-driven, patient centric ecosystem.

The convergence of AI, real world evidence, digital therapeutics, and precision medicine is enabling more targeted interventions and personalized care pathways. Connected platforms spanning remote monitoring, predictive analytics, and patient support programs—are transforming engagement across the product lifecycle, from clinical development to post-market management. Patients are now active participants, empowered through access to information, digital tools, and real-time feedback loops that drive better adherence and informed decision-making.

For pharmaceutical leaders, this shift presents an opportunity to integrate patient perspectives into every stage of innovation. Digital trials and decentralized research models expand participation and enhance diversity, while AI-driven insights enable faster recruitment, improved trial design, and more representative data. Post-launch, digital engagement solutions sustain communication, reinforce adherence, and generate real-world data that strengthens value demonstration and market access. As healthcare systems evolve toward value-based and outcomes driven models, patient engagement sits at the intersection of innovation, access, and accountability. Success will depend on the industry’s ability to harness data interoperability, responsible AI, and ethical data governance to ensure transparency, privacy, and equitable participation.

However, challenges remain. Digital inequity, fragmented infrastructures, data silos, and clinician resistance continue to slow progress. Overcoming these barriers will require cross sector collaboration, regulatory alignment, and a shared commitment to patient-centered design. Investment in education, digital literacy, and ecosystem interoperability will be critical to sustaining engagement and trust. At this congress, our goal is to unite leaders across healthcare and life sciences to align on a shared vision for digital maturity and connected care. Together, we will explore actionable strategies to accelerate adoption, measure impact, and scale innovation that truly serves patients.

The next era of healthcare will be defined not just by technological advancement, but by how effectively we integrate empathy, evidence, and innovation to deliver meaningful, measurable outcomes. Patient engagement is no longer optional—it is the foundation of sustainable growth and improved global health.

We look forward to meeting you at the Congress! 

Sincerely yours,

Jocelyn Raguindin
Conference Director
Paradigm Global Events / Facilitate Live 

GAIN LATEST INSIGHTS ON:

WHO SHOULD ATTEND?

This conference on Patient Engagement Solutions and Innovations is designed for professionals, leaders, and innovators across the healthcare ecosystem.

It brings together experts from clinical, pharma & Biotech, technological, academic, and policy backgrounds who are driving or supporting patient-centered transformation.

Network with Presidents, Heads/Chiefs, VPs, Directors, and Managers in the area of:

Key Industry Expert Speakers 2026

LARA BLOOM

President and CEO

The Ehlers-Danlos Society

STEVE CLARK

Founder and Patient Advocate

Strive for Five

Emma Sutcliffe

Global Patient Officer

Ipsen

Dr Liz Clarke

Visiting Lecturer and Patient Engagement Theme Lead

Centre for Pharmaceutical Medicines Research, Kings College London

Robert Mitchell-Thain

CEO

PBC Foundation

Keith Berelowitz

Founder/CEO

pRxEngage Inc.

CAROLE SCRAFTON

CEO & Co-Founder Patient Advocacy Organisation

FibroFlutters

Senior Representative

Available Shortly - Coming Soon

Pharma

Senior Representative

Director of Patient Advocacy

Pharma - Biotech

SVP, Patient Affairs

Available Shortly - Coming Soon

Sarepta Therapeutics

Senior Representative

Head of Country Operations

Alexion Pharmaceuticals

Project Manager

Available Shortly - Coming Soon

Alexion

StudStart-up Manager

Available Shortly - Coming Soon

Alexion Astrazeneca

Senior Representative

Available Shortly - Coming Soon

Novartis

Senior Representative

Available Shortly - Coming Soon

Pharma

Senior Representative

Available Shortly - Coming Soon

Biotech

Schedule

Content Rich Program Agenda!  Featuring Keynote Presentations, Stream Sessions, Panel, and Round Table Discussions.

SCALING PATIENT ENGAGEMENT FOR MEASURABLE IMPACT

  • What frameworks successfully integrate engagement into R&D, commercial, and medical functions?
  • How can organizations operationalize engagement as a strategic business capability?
  • What governance models ensure consistency across markets and therapeutic areas?
  • Which KPIs demonstrate success across enterprise-level engagement programs?

Moderator:


Panellists:

  • How can pharmaceutical companies effectively embed patient input into every stage of the product lifecycle?
  • What organizational structures or roles are most effective in championing patient engagement?
  • How can agile and co-creation models be utilized to accelerate innovation in a patient-centric framework?
  • What types of partnerships are most valuable in creating measurable value during real-world implementation of these models?
  • What outcome-based indicators effectively measure patient engagement success?
  • How can data-driven dashboards link engagement to clinical and economic results?
  • How do we monetize engagement outcomes without compromising ethics?
  • What ROI models resonate most with executives and investors?
  • How can global frameworks adapt to local health systems and cultures?
  • What governance ensures compliance while enabling flexibility?
  • How can digital platforms localize content without fragmenting experience?
  • Which markets are setting the benchmark for scalable patient engagement?
  • How patient co-creation can evolve from superficial input to a genuine partnership?
  • What tools are available to support the rapid prototyping and testing of engagement solutions?
  • How cross-functional teams can effectively apply design thinking at scale?
  • What the measurable business outcomes of co-creation programs typically are?
  • What collaboration models best unite pharma, payers, providers, and tech partners?
  • How can joint platforms accelerate engagement innovation?
  • What contractual and data frameworks best facilitate shared success metrics?
  • How multi-stakeholder alliances can scale patient impact globally.

ENABLING CONNECTED, PERSONALIZED & INTELLIGENT SOLUTIONS

  • How engagement tools, wearables, and EHRs can be harmonized effectively?
  • Architectural frameworks that support interoperability and secure data exchange within such ecosystems.
  • How integrated platforms can mitigate patient friction and reduce data redundancy?
  • Sustainable business models that support these ecosystems long-term.
  • Proven AI solutions that enhance patient engagement and adherence.
  • How predictive models can personalize interventions while respecting patient privacy?
  • Strategies for ensuring human oversight and accountability in AI programs.
  • Regulatory and ethical guardrails that apply to AI in patient engagement.
  • How can pharma integrate digital therapeutics into patient support journeys?
  • What evidence frameworks validate their clinical and behavioral impact?
  • How digital therapeutics data can inform real-world outcomes and market access strategies
  • Commercialization models that sustain long-term use and adherence?
  • How can engagement platforms be effectively utilized to capture high-quality real-world data?
  • What specific tools and methodologies are available to link patient-generated data with clinical and commercial insights?
  • In what ways can real-time feedback loops, facilitated by these platforms, enhance treatment optimization and patient outcomes?
  • What governance frameworks and best practices are essential to ensure the integrity, representativeness, and ethical use of RWE collected through these platforms?
  • Can blockchain address transparency and data ownership concerns?
  • How blockchain can streamline compliance processes while simultaneously safeguarding data integrity?
  • What barriers stand in the way of implementation?
  • Effective strategies for communicating its advantages to patients.
  • Critical intersection of technological advancements and the indispensable need for human empathy in various fields
  • Delve into real-world examples of compassionate digital care illustrating how technology can be leveraged to enhance, rather than diminish, genuine human connection and support
  • Provider perspectives on the challenges of engaging individuals in a digitally-driven environment, offering valuable insights into overcoming these hurdles
  • How to effectively integrate innovation with empathy to create more impactful and human-centered solutions.

6:15 - 7:15 pm - NETWORKING DRINK RECEPTION

ENSURING EQUITY, TRUST & ACCESSIBILITY IN ENGAGEMENT INNOVATION

  • What specific design principles can be implemented to ensure that digital health platforms and tools are truly inclusive and cater to a diverse user base?
  • Methods to address barriers like varying digital literacy, language differences, and cultural nuances.
  • Partnership opportunities with community organizations, non-profits, and local leaders to expand access in underrepresented populations.
  • Methodologies and metrics for evaluating engagement programs to ensure equitable outcomes and reduce health disparities.

Moderator:

Panellists:

  • Key strategies for enhancing digital inclusion within this demographic.
  • The importance of training and education initiatives tailored for patients.
  • The necessity of designing user-friendly and inclusive digital platforms.
  • The significant role that governments and NGOs play in improving digital access for all.
  • Practical steps for ensuring that digital transformation also means equitable transformation.
  • Technologies available to simplify multi-jurisdictional compliance with regulations.
  • How privacy-by-design frameworks can accelerate engagement deployment?
  • What cross-border models facilitate compliant data exchange?
  • Strategies for the pharmaceutical industry to establish itself as a leader in digital trust

PATIENT ENGAGEMENT SOLUTIONS IN CLINICAL TRIALS

  • How can engagement be redefined as a strategic driver of recruitment and retention in healthcare and pharma?
  • What digital and cultural innovations most effectively sustain workforce wellbeing and motivation?
  • How can leadership and employee experience be aligned to mission and patient impact?
  • What practical strategies bridge the gap between employee voice, inclusion, and operational excellence?
  • What role do AI chatbots or virtual assistants play in improving patient communication and adherence?
  • How can remote monitoring and decentralized trial platforms balance convenience with data accuracy and compliance?
  • How might continuous feedback loops between patients and researchers transform protocol design and responsiveness?
  • Which metrics best capture meaningful engagement in clinical research?
  • How can participant-reported outcomes (PROs) be used to refine study protocols and improve real-world relevance?
  • How does strong patient engagement contribute to faster approvals and more reliable study results?
  • How can sponsors and CROs demonstrate the ROI of patient engagement initiatives in trials?

ENHANCING COMMUNICATION AND COLLABORATION

  • How can digital platforms improve clarity and timeliness in provider–patient communication?
  • What strategies can ensure that technology enhances human empathy in care interactions?
  • How can clinicians be effectively trained to use digital communication tools while maintaining a personal connection with patients?
  • What role does real-time data sharing play in empowering patients to take a more active role in their healthcare decision-making?
  • How can healthcare systems integrate families and caregivers into digital care plans while protecting patient privacy?
  • What digital solutions best support collaboration between patients, caregivers, and clinical teams?
  • How can caregivers’ feedback and experiences be incorporated to enhance care coordination and patient outcomes?
  • Technological approaches alleviating caregiver burden while strengthening their role in ongoing patient support.
  • Insight into how culturally sensitive and multilingual communication tools can reduce disparities in patient engagement?
  • Effective strategies for leveraging social media and online communities to foster patient-to-patient support.
  • How can healthcare organizations use patient feedback from online platforms to refine care delivery and experience?
  • What safeguards are needed to ensure authenticity, trust, and accuracy in digital patient communities?
  • How can healthcare organizations, Pharma and technology vendors align with HIPAA, GDPR, and other global privacy regulations while fostering innovation?
  • Most effective methods for communicating data usage and obtaining informed patient consent in digital health.
  • How can we ensure AI-driven recommendations and decision-support systems are transparent, unbiased, and ethical?
  • Trends that will shape engagement leadership in the coming decade.
  • Evolving role of pharmaceutical and healthcare companies in a data-literate patient environment.
  • Emerging technologies that will create a competitive advantage.
  • How we can maintain a human-centered approach to engagement?

Event Partners

Sponsors & Exhibitors - Patient Engagement Solutions & Innovations World Congress 2026 Europe

Newsletter Sign Up

No Spam – You will only receive relevant information on Patient Centricity & Collaboration, and event updates

Testimonials

what people say

Thank you for a good experience with the PARADIGM Global Events… very high level, very good Organization, we overpassed our expectatives, we will be pending for another congress related to pharmaceutical and biotech… we learned a lot, and i think that the content of agenda was state of the art, thank you again.
Salvador Berrios
ERP/ CRM / Product Configurator Manager
The consistently high quality of international faculty was most impressive. It was also obvious that they were carefully chosen not only for their particular expertise but also for their ability to communicate the subject matter to clinical and non-clinical participants alike. As market access consultant for pharma clients of various sizes, I now feel much better prepared to explain the nuances & dynamics involved in bringing their products to market. In addition, I am in a much better position to intelligently advice my clients & help them set realistic expectations
Thomas Martin
Associate Vice President, VCGA - Quintiles
I was impressed with the organization of this event. I attend many conferences per year and find the organizers on site to be detached and not focus on good service to the delegates. This team was even providing weather forecast warning to ensure everyone was aware and made appropriate plans. Well Done.
Adriana E. Manzi
PhD, Managing Director, Atheln, Inc

Previous events

Book Your Place Now! 

Register To Attend Now!

Take Advantage of the Super Early Bird Discount. Group Discounts Also Available. 

Location

Scroll to Top
Update cookies preferences